Two cases of vitiligo vulgaris treated with topical Janus kinase inhibitor delgocitinib
暂无分享,去创建一个
[1] S. Shumack,et al. Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis , 2020, The Journal of dermatological treatment.
[2] N. Mesinkovska,et al. Topical Janus kinase inhibitors: A review of applications in dermatology , 2018, Journal of the American Academy of Dermatology.
[3] A. Gottlieb,et al. Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib , 2017, Journal of the American Academy of Dermatology.
[4] V. Rigau,et al. Bier anaemic spots, cyanosis with urticaria‐like eruption (BASCULE) syndrome: a new entity? , 2016, The British journal of dermatology.
[5] B. King,et al. Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy. , 2015, JAMA dermatology.